Particularly if the market decides to classify ZNO as a nanotechnology company (which it is), then you get a P/E re-rate on top of the growing earnings. In the near term, it may be effectively viewed as a discretionary consumer goods company or worse, a coronavirus fad that's going to go away (sells hand sanitiser).
You will see the market assign a higher PE for the likes of ANO, NAN etc. In my mind these are the type of companies in Zoono's peer group to benchmark against.
Company websites mentioning use of Zoono, page-37
-
- There are more pages in this discussion • 2,723 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
